APA (7th ed.) Citation

N. Madrid-Elena, L. García-Bermejo, Adíaz-De Santiago, S. Serrano-Villar, F. Dronda, B. Sastre-Turrón, . . . S. Moreno Guillén. (2016). 30LB Maraviroc administration is associated to reversion of latent HIV-1 through NFkB in ART suppressed patients. Elsevier.

Chicago Style (17th ed.) Citation

N. Madrid-Elena, L. García-Bermejo, Adíaz-De Santiago, S. Serrano-Villar, F. Dronda, B. Sastre-Turrón, C. Gutierrez, B. Hernández-Novoa, and S. Moreno Guillén. 30LB Maraviroc Administration Is Associated to Reversion of Latent HIV-1 Through NFkB in ART Suppressed Patients. Elsevier, 2016.

MLA (9th ed.) Citation

N. Madrid-Elena, et al. 30LB Maraviroc Administration Is Associated to Reversion of Latent HIV-1 Through NFkB in ART Suppressed Patients. Elsevier, 2016.